National Comprehensive Cancer Network



NCCN Oncology Research Program (ORP)
NCCN Volasertib Research Grant Opportunity – Submit by October 30, 2014
NCCN ORP Recent News
NCCN ORP Affiliate Research Consortium
NCCN ORP Scientific Publications
NCCN ORP for Industry
NCCN ORP Investigator Steering Committee
NCCN ORP Testimonials
NCCN Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
NCCN ORP Grant History
NCCN Informed Consent Language Database
NCCN Specialized Imaging Research Consortium™ (SIRC)
NCCN ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees

NCCN Research & Business Resources

Head and Neck Cancers Guidelines updated to include option of PET-CT and CT with contrast in several cancer sites

The NCCN Clinical Practice Guidelines in Oncology™ for Head and Neck Cancers have been updated to include PET-CT and CT with contrast as an option for workup in several cancer sites, including oropharynx, hypopharynx, glottic larynx, supraglottic larynx, and nasopharynx. A post-treatment evaluation with imaging was added to assist in patient selection for neck dissection for cancer sites including lip, oropharynx, hypopharynx, occult primary, glottic larynx, and supraglottic larynx.

Updates were also made with regards to radiation therapy, with altered fractionation schedules added to cancer sites including maxillary sinus tumors, oral cavity, oropharynx, hypopharynx, occult primary, and supraglottic larynx. A “Radiation Techniques” page was created to provide further guidance on radiation treatment, including Intensity-Modulated Radiotherapy (IMRT) and Fractionation.